Tommaso Colangelo
Overview
Explore the profile of Tommaso Colangelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mattoscio D, Baeza L, Bai H, Colangelo T, Castagnozzi S, Marzotto M, et al.
FEBS J
. 2025 Mar;
PMID: 40029006
Cystic fibrosis (CF) is a genetic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, leading to chronic, unresolved inflammation of the airways due to uncontrolled recruitment...
2.
Circadian patterns of growth factor receptor-dependent signaling and implications for carcinogenesis
Murgo E, Falco G, Serviddio G, Mazzoccoli G, Colangelo T
Cell Commun Signal
. 2024 Jun;
22(1):319.
PMID: 38858728
Several different signaling pathways that regulate cell proliferation and differentiation are initiated by binding of ligands to cell-surface and membrane-bound enzyme-linked receptors, such as receptor tyrosine kinases and serine-threonine kinases....
3.
Pannone G, Pedicillo M, De Stefano I, Angelillis F, Barile R, Pannone C, et al.
Cells
. 2024 May;
13(10.
PMID: 38786077
Methods: The aim of this study was to study the expression of platelet glycoprotein IIIa (CD61), playing a critical role in platelet aggregation, together with TRL-2 as a marker of...
4.
Sangineto M, Ciarnelli M, Colangelo T, Moola A, Naik Bukke V, Duda L, et al.
Cell Rep Med
. 2024 May;
5(5):101564.
PMID: 38733988
Monocytes (Mos) are crucial in the evolution of metabolic dysfunction-associated steatotic liver disease (MASLD) to metabolic dysfunction-associated steatohepatitis (MASH), and immunometabolism studies have recently suggested targeting leukocyte bioenergetics in inflammatory...
5.
Murgo E, Colangelo T, Bellet M, Malatesta F, Mazzoccoli G
Biology (Basel)
. 2023 Oct;
12(10).
PMID: 37887064
Neuronal PAS domain protein 2 (NPAS2) is a hemeprotein comprising a basic helix-loop-helix domain (bHLH) and two heme-binding sites, the PAS-A and PAS-B domains. This protein acts as a pyridine...
6.
Pedicillo M, De Stefano I, Zamparese R, Barile R, Meccariello M, Agostinone A, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686069
To the current data, there have been 6,955,141 COVID-19-related deaths worldwide, reported to WHO. Toll-like receptors (TLRs) implicated in bacterial and virus sensing could be a crosstalk between activation of...
7.
Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, et al.
J Exp Clin Cancer Res
. 2023 Aug;
42(1):218.
PMID: 37620852
Background: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy, characterized by restricted cellular subsets with asymmetrically enriched leukemia initiating cell (LIC) activity. Nonetheless, it is still unclear which...
8.
Quarato C, Dama E, Maggi M, Feragalli B, Borelli C, Del Colle A, et al.
Front Med (Lausanne)
. 2023 Jun;
10:1146807.
PMID: 37261121
Objectives: We validated a screening protocol in which thoracic ultrasound (TUS) acts as a first-line complementary imaging technique in selecting patients which may deserve a second-line low-dose high resolution computed...
9.
Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi M, Mazzarelli F, et al.
J Hematol Oncol
. 2022 Dec;
15(1):178.
PMID: 36587234
Locally advanced non-small cell lung cancer (NSCLC) is frequent at diagnosis and requires multimodal treatment approaches. Neoadjuvant chemotherapy (NACT) followed by surgery is the treatment of choice for operable locally...
10.
Colangelo T, Panelli P, Mazzarelli F, Tamiro F, Melocchi V, De Santis E, et al.
Mol Cancer
. 2022 Dec;
21(1):226.
PMID: 36550553
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive T-cell malignancy characterized by genotypically-defined and phenotypically divergent cell populations, governed by adaptive landscapes. Clonal expansions are associated to genetic and epigenetic...